Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
The International Journal of Biological Markers
|
October 1, 1991
Urinary neopterin in malignant lymphoma
L Piccinini, S Zironi, M Federico, et al.
Tumori
|
June 30, 1990
Prevention of cisplatin-induced vomiting in patients with cancer. A pilot study with a multiagent protocol
M Federico, R Sabbatini, P Piccinini, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|
September 1, 1993
Soluble interleukin-2 receptor and urinary neopterin concentrations in malignant lymphoma
L Piccinini, S Zironi, A M Cenci, et al.
Breast Cancer Research and Treatment
|
August 6, 2002
Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition
G Del Rio, S Zironi, L Valeriani, et al.
American Journal of Clinical Oncology
|
June 1, 1996
High-dose folinic acid and fluorouracil with or without ifosfamide is an inactive combination in advanced pancreatic cancer. A randomized phase II study of the Italian Oncology Group for Clinical Research (G.O.I.R.C.)
F Di Costanzo, M Tagliaventi, P Carlini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research
G Cocconi, M Bella, S Zironi, et al.
British Journal of Cancer
|
September 16, 2010
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
C Bengala, S Bettelli, F Bertolini, et al.
American Journal of Clinical Oncology
|
June 17, 2000
Modulation of fluorouracil by methotrexate, leucovorin, and cisplatin (M-FLP) in the treatment of advanced pancreatic cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC)
F Di Costanzo, R Canaletti, A Sdrobolini, et al.
British Journal of Cancer
|
November 26, 2009
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
C Bengala, F Bertolini, N Malavasi, et al.
American Journal of Clinical Oncology
|
August 26, 1998
High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research
F Di Costanzo, S Gasperoni, P Malacarne, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
The International Journal of Biological Markers
|
October 1, 1991
Urinary neopterin in malignant lymphoma
L Piccinini, S Zironi, M Federico, et al.
Tumori
|
June 30, 1990
Prevention of cisplatin-induced vomiting in patients with cancer. A pilot study with a multiagent protocol
M Federico, R Sabbatini, P Piccinini, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|
September 1, 1993
Soluble interleukin-2 receptor and urinary neopterin concentrations in malignant lymphoma
L Piccinini, S Zironi, A M Cenci, et al.
Breast Cancer Research and Treatment
|
August 6, 2002
Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition
G Del Rio, S Zironi, L Valeriani, et al.
American Journal of Clinical Oncology
|
June 1, 1996
High-dose folinic acid and fluorouracil with or without ifosfamide is an inactive combination in advanced pancreatic cancer. A randomized phase II study of the Italian Oncology Group for Clinical Research (G.O.I.R.C.)
F Di Costanzo, M Tagliaventi, P Carlini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research
G Cocconi, M Bella, S Zironi, et al.
British Journal of Cancer
|
September 16, 2010
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
C Bengala, S Bettelli, F Bertolini, et al.
American Journal of Clinical Oncology
|
June 17, 2000
Modulation of fluorouracil by methotrexate, leucovorin, and cisplatin (M-FLP) in the treatment of advanced pancreatic cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC)
F Di Costanzo, R Canaletti, A Sdrobolini, et al.
British Journal of Cancer
|
November 26, 2009
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
C Bengala, F Bertolini, N Malavasi, et al.
American Journal of Clinical Oncology
|
August 26, 1998
High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research
F Di Costanzo, S Gasperoni, P Malacarne, et al.
Page
of 2